{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:00Z","timestamp":1786980540924,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02364801"],"award-info":[{"award-number":["RF-2016-02364801"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FICEF Onlus"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10072-022-06164-y","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T23:43:11Z","timestamp":1653608591000},"page":"5717-5724","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Addressing the cost of chronic and episodic migraine and its main drivers: a short-term longitudinal analysis from a third-level Italian center"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7433-7779","authenticated-orcid":false,"given":"Alberto","family":"Raggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6535-1109","authenticated-orcid":false,"given":"Licia","family":"Grazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-0207","authenticated-orcid":false,"given":"Erika","family":"Guastafierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5003-1409","authenticated-orcid":false,"given":"Alessia","family":"Marcassoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0744-7051","authenticated-orcid":false,"given":"Marco","family":"Passavanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-2045","authenticated-orcid":false,"given":"Danilo Antonio","family":"Montisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5016-9301","authenticated-orcid":false,"given":"Domenico","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"4","key":"6164_CR1","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1007\/s00415-021-10774-5","volume":"269","author":"A Raggi","year":"2022","unstructured":"Raggi A, Monasta L, Beghi E, Caso V, Castelpietra G, Mondello S, Giussani G, Logroscino G, Magnani FG, Piccininni M, Pupillo E, Ricci S, Ronfani L, Santalucia P, Sattin D, Schiavolin S, Toppo C, Traini E, Steinmetz J, Nichols E, Ma R, Vos T, Feigin V, Leonardi M (2022) Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019. J Neurol 269(4):2080\u20132098. https:\/\/doi.org\/10.1007\/s00415-021-10774-5","journal-title":"J Neurol"},{"issue":"1","key":"6164_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38(1):1\u2013211. https:\/\/doi.org\/10.1177\/0333102417738202","journal-title":"Cephalalgia"},{"issue":"23","key":"6164_CR3","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1001\/jama.2021.7939","volume":"325","author":"JH VanderPluym","year":"2021","unstructured":"VanderPluym JH, Halker Singh RB, Urtecho M, Morrow AS, Nayfeh T, Torres Roldan VD, Farah MH, Hasan B, Saadi S, Shah S, Abd-Rabu R, Daraz L, Prokop LJ, Murad MH, Wang Z (2021) Acute treatments for episodic migraine in adults: a systematic review and meta-analysis. JAMA 325(23):2357\u20132369. https:\/\/doi.org\/10.1001\/jama.2021.7939","journal-title":"JAMA"},{"issue":"4","key":"6164_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ncl.2019.07.006","volume":"37","author":"SJ Tepper","year":"2019","unstructured":"Tepper SJ (2019) Acute treatment of migraine. Neurol Clin 37(4):727\u2013742. https:\/\/doi.org\/10.1016\/j.ncl.2019.07.006","journal-title":"Neurol Clin"},{"issue":"8","key":"6164_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12(8):455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"issue":"Suppl 2","key":"6164_CR6","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1007\/s10194-012-0437-6","volume":"13","author":"P Sarchielli","year":"2012","unstructured":"Sarchielli P, Granella F, Prudenzano MP, Pini LA, Guidetti V, Bono G, Pinessi L, Alessandri M, Antonaci F, Fanciullacci M, Ferrari A, Guazzelli M, Nappi G, Sances G, Sandrini G, Savi L, Tassorelli C, Zanchin G (2012) Italian guidelines for primary headaches: 2012 revised version. J Headache Pain 13(Suppl 2):S31\u2013S70. https:\/\/doi.org\/10.1007\/s10194-012-0437-6","journal-title":"J Headache Pain"},{"issue":"1","key":"6164_CR7","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-019-1038-4","volume":"20","author":"EC Agostoni","year":"2019","unstructured":"Agostoni EC, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F, Geppetti P, Grazzi L, Leone M, Martelletti P, Pini LA, Prudenzano MP, Sarchielli P, Tedeschi G, Russo A (2019) Italian chronic migraine group. Current and emerging evidence-based treatment options in chronic migraine: a narrative review. J Headache Pain 20(1):92. https:\/\/doi.org\/10.1186\/s10194-019-1038-4","journal-title":"J Headache Pain"},{"issue":"4","key":"6164_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/ijerph18041503","volume":"18","author":"L Grazzi","year":"2021","unstructured":"Grazzi L, Toppo C, D\u2019Amico D, Leonardi M, Martelletti P, Raggi A, Guastafierro E (2021) Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health 18(4):1503. https:\/\/doi.org\/10.3390\/ijerph18041503","journal-title":"Int J Environ Res Public Health"},{"key":"6164_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/j.1468-1331.2011.03612.x","volume":"19","author":"M Linde","year":"2012","unstructured":"Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barr\u00e9 J, Katsarava Z, Lainez JM, Lampl C, Lant\u00e9ri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andr\u00e9e C (2012) The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 19:703\u2013711. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03612.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"6164_CR10","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ene.14034","volume":"27","author":"A Raggi","year":"2020","unstructured":"Raggi A, Leonardi M, Sansone E, Curone M, Grazzi L, D\u2019Amico D (2020) The cost and the value of treatment of medication overuse headache in Italy: a longitudinal study based on patient-derived data. Eur J Neurol 27(1):62-e1. https:\/\/doi.org\/10.1111\/ene.14034","journal-title":"Eur J Neurol"},{"issue":"Suppl 2","key":"6164_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10072-020-04662-5","volume":"41","author":"E Sansone","year":"2020","unstructured":"Sansone E, Grazzi L, Raggi A, Leonardi M, D\u2019Amico D (2020) Mindfulness as an add-on treatment for patients with chronic migraine and medication overuse: a preliminary analysis. Neurol Sci 41(Suppl 2):469\u2013471. https:\/\/doi.org\/10.1007\/s10072-020-04662-5","journal-title":"Neurol Sci"},{"issue":"1","key":"6164_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/head.12979","volume":"57","author":"A Raggi","year":"2017","unstructured":"Raggi A, Giovannetti AM, Leonardi M, Sansone E, Schiavolin S, Curone M, Grazzi L, Usai S, D\u2019Amico D (2017) Predictors of 12-months relapse after withdrawal treatment in hospitalized patients with chronic migraine associated with medication overuse: a longitudinal observational study. Headache 57(1):60\u201370. https:\/\/doi.org\/10.1111\/head.12979","journal-title":"Headache"},{"issue":"9","key":"6164_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1111\/j.1468-1331.2011.03497.x","volume":"18","author":"S Evers","year":"2011","unstructured":"Evers S, Jensen R, Federation E, of Neurological Societies, (2011) Treatment of medication overuse headache\u2013guideline of the EFNS headache panel. Eur J Neurol 18(9):1115\u201321. https:\/\/doi.org\/10.1111\/j.1468-1331.2011.03497.x","journal-title":"Eur J Neurol"},{"issue":"1","key":"6164_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/head.14018","volume":"61","author":"RB Lipton","year":"2021","unstructured":"Lipton RB, Buse DC, Dodick DW, Schwedt TJ, Singh P, Munjal S, Fanning K, Bostic Bs R, Reed ML (2021) Burden of increasing opioid use in the treatment of migraine: results from the Migraine in America Symptoms and Treatment Study. Headache 61(1):103\u2013116. https:\/\/doi.org\/10.1111\/head.14018","journal-title":"Headache"},{"issue":"5","key":"6164_CR15","doi-asserted-by":"publisher","first-page":"e457","DOI":"10.1212\/WNL.0000000000009324","volume":"95","author":"RB Lipton","year":"2020","unstructured":"Lipton RB, Buse DC, Friedman BW, Feder L, Adams AM, Fanning KM, Reed ML, Schwedt TJ (2020) Characterizing opioid use in a US population with migraine: results from the CaMEO study. Neurology 95(5):e457\u2013e468. https:\/\/doi.org\/10.1212\/WNL.0000000000009324","journal-title":"Neurology"},{"issue":"1 Suppl","key":"6164_CR16","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.37765\/ajmc.2020.42544","volume":"26","author":"A Kangethe","year":"2020","unstructured":"Kangethe A, Polson M, Evangelatos TM, Speicher LC, Tenaglia AT, Staats PS, Liebler EJ, Mwamburi M (2020) Real-world assessment of concomitant opioid utilization and associated trends in patients with migraine. Am J Manag Care. 26(1 Suppl):S8\u2013S14. https:\/\/doi.org\/10.37765\/ajmc.2020.42544","journal-title":"Am J Manag Care."},{"issue":"9","key":"6164_CR17","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1177\/0333102419835465","volume":"39","author":"M Bonafede","year":"2019","unstructured":"Bonafede M, Wilson K, Xue F (2019) Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine. Cephalalgia 39(9):1086\u20131098. https:\/\/doi.org\/10.1177\/0333102419835465","journal-title":"Cephalalgia"},{"issue":"1","key":"6164_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/head.12266","volume":"54","author":"M Levin","year":"2014","unstructured":"Levin M (2014) Opioids in headache. Headache 54(1):12\u201321. https:\/\/doi.org\/10.1111\/head.12266","journal-title":"Headache"},{"issue":"4","key":"6164_CR19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jpain.2016.12.004","volume":"18","author":"BJ Morasco","year":"2017","unstructured":"Morasco BJ, Yarborough BJ, Smith NX, Dobscha SK, Deyo RA, Perrin NA, Green CA (2017) Higher prescription opioid dose is associated with worse patient-reported pain outcomes and more health care utilization. J Painv 18(4):437\u2013445. https:\/\/doi.org\/10.1016\/j.jpain.2016.12.004","journal-title":"J Painv"},{"issue":"19","key":"6164_CR20","doi-asserted-by":"publisher","first-page":"e15487","DOI":"10.1097\/MD.0000000000015487","volume":"98","author":"W Jiang","year":"2019","unstructured":"Jiang W, Li Z, Wei N, Chang W, Chen W, Sui HJ (2019) Effectiveness of physical therapy on the suboccipital area of patients with tension-type headache: a meta-analysis of randomized controlled trials. Medicine (Baltimore) 98(19):e15487. https:\/\/doi.org\/10.1097\/MD.0000000000015487","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"6164_CR21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1179\/2042618612Y.0000000025","volume":"21","author":"S Racicki","year":"2013","unstructured":"Racicki S, Gerwin S, Diclaudio S, Reinmann S, Donaldson M (2013) Conservative physical therapy management for the treatment of cervicogenic headache: a systematic review. J Man Manip Ther 21(2):113\u201324. https:\/\/doi.org\/10.1179\/2042618612Y.0000000025","journal-title":"J Man Manip Ther"},{"key":"6164_CR22","doi-asserted-by":"publisher","first-page":"102277","DOI":"10.1016\/j.msksp.2020.102277","volume":"50","author":"HA Van der Meer","year":"2020","unstructured":"Van der Meer HA, Calixtre LB, Engelbert RHH, Visscher CM, Nijhuis-van der Sanden MW, Speksnijder CM (2020) Effects of physical therapy for temporomandibular disorders on headache pain intensity: a systematic review. Musculoskelet Sci Pract 50:102277. https:\/\/doi.org\/10.1016\/j.msksp.2020.102277","journal-title":"Musculoskelet Sci Pract"},{"key":"6164_CR23","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s11916-010-0147-1","volume":"14","author":"A Blumenfeld","year":"2010","unstructured":"Blumenfeld A, Schim J, Brower J (2010) Pure tension-type headache versus tension-type headache in the migraineur. Curr Pain Headache Rep 14:465\u2013469. https:\/\/doi.org\/10.1007\/s11916-010-0147-1","journal-title":"Curr Pain Headache Rep"},{"key":"6164_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S1474-4422(09)70090-0","volume":"8","author":"J Olesen","year":"2009","unstructured":"Olesen J, Burstein R, Ashina M, Tfelt-Hansen P (2009) Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 8:679\u2013690. https:\/\/doi.org\/10.1016\/S1474-4422(09)70090-0","journal-title":"Lancet Neurol"},{"key":"6164_CR25","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","volume":"12","author":"A May","year":"2016","unstructured":"May A, Schulte LH (2016) Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 12:455\u2013464. https:\/\/doi.org\/10.1038\/nrneurol.2016.93","journal-title":"Nat Rev Neurol"},{"key":"6164_CR26","unstructured":"Federfarma. https:\/\/www.federfarma.it\/Farmaci-e-farmacie\/Cerca-un-farmaco.aspx (Accessed 17\/02\/2022)"},{"key":"6164_CR27","unstructured":"AIFA (Italian Drugs Agency). https:\/\/www.aifa.gov.it\/en\/-\/modifica-registri-aimovig-ajovy-ed-emgality-emicrania- (Accessed 17\/02\/2022)"},{"issue":"2","key":"6164_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/head.14032","volume":"61","author":"P Barbanti","year":"2021","unstructured":"Barbanti P, Aurilia C, Egeo G, Fofi L, Cevoli S, Colombo B, Filippi M, Frediani F, Bono F, Grazzi L, Salerno A, Mercuri B, Carnevale A, Altamura C, Vernieri F (2021) Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study. Headache 61(2):363\u2013372. https:\/\/doi.org\/10.1111\/head.14032","journal-title":"Headache"},{"issue":"1","key":"6164_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s10194-021-01247-1","volume":"22","author":"F Vernieri","year":"2021","unstructured":"Vernieri F, Altamura C, Brunelli N, Costa CM, Aurilia C, Egeo G, Fofi L, Favoni V, Pierangeli G, Lovati C, Aguggia M, d\u2019Onofrio F, Doretti A, Di Fiore P, Finocchi C, Rao R, Bono F, Ranieri A, Albanese M, Cevoli S, Barbanti P, GARLIT Study Group (2021) Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study). J Headache Pain 22(1):35","journal-title":"J Headache Pain"},{"issue":"1","key":"6164_CR30","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s10194-021-01363-y","volume":"22","author":"F Vernieri","year":"2021","unstructured":"Vernieri F, Brunelli N, Messina R, Costa CM, Colombo B, Torelli P, Quintana S, Cevoli S, Favoni V, d\u2019Onofrio F, Egeo G, Rao R, Filippi M, Barbanti P, Altamura C (2021) Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study. J Headache Pain 22(1):154. https:\/\/doi.org\/10.1186\/s10194-021-01363-y","journal-title":"J Headache Pain"},{"key":"6164_CR31","unstructured":"Gazzetta Ufficiale della Repubblica Italiana, 21\/07\/2020. Italian Drugs Agency determination of cost and administration of erenumab, galcanezumab and fremanezumab https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2020\/07\/21\/182\/sg\/pdf (Accessed 17\/02\/2022)"},{"key":"6164_CR32","doi-asserted-by":"publisher","unstructured":"Pensato U, Baraldi C, Favoni V, Mascarella D, Matteo E, Andrini G, Cainazzo MM, Cortelli P, Pierangeli G, Guerzoni S, Cevoli S (2022) Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache. Cephalalgia. Epub ahead of print. On Feb 9, 2022. https:\/\/doi.org\/10.1177\/03331024211067791.","DOI":"10.1177\/03331024211067791"},{"issue":"6","key":"6164_CR33","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/head.13337","volume":"58","author":"A Raggi","year":"2018","unstructured":"Raggi A, Grignani E, Leonardi M, Andrasik F, Sansone E, Grazzi L, D\u2019Amico D (2018) Behavioral approaches for primary headaches: recent advances. Headache 58(6):913\u2013925. https:\/\/doi.org\/10.1111\/head.13337","journal-title":"Headache"},{"issue":"5","key":"6164_CR34","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1007\/s10072-018-3280-y","volume":"39","author":"P Barbanti","year":"2018","unstructured":"Barbanti P, Fofi L, Cevoli S, Torelli P, Aurilia C, Egeo G, Grazzi L, D\u2019Amico D, Manzoni GC, Cortelli P, Infarinato F, Vanacore N (2018) Establishment of an Italian chronic migraine database: a multicenter pilot study. Neurol Sci 39(5):933\u2013937. https:\/\/doi.org\/10.1007\/s10072-018-3280-y","journal-title":"Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06164-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06164-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:09:51Z","timestamp":1660694991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06164-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["6164"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06164-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"assertion":[{"value":"11 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}